Navigation Links
iE33 Echocardiography System

ProductsiE33 Echocardiography System
Company Philips Medical Systems
Item iE33 Echocardiography System
Features 
  • S5-1 transducer with exclusive PureWave crystal technology provides striking 2D clarity and color sensitivity
  • X3-1 with xMATRIX array technology incorporates the processing power of 150 computer boards for real-time 3D volume rendered imaging
  • xMATRIX transducer technology incorporates exclusive micro-beamforming circuitry designed to support up to 3,000 individual active elements
  • Live xPlane imaging
  • SonoCT real-time compound imaging
  • XRES image processing
Description The iE33 is a 3D quantitative echo system that will change the way echo exams are performed. Intelligent design and intelligent control combine to bring you revolutionary clinical performance and workflow. The iE33 systems xSTREAM architecture processes multiple data streams simultaneously and incorporates a distributed multi-processor environment that achieves an extraordinary 250 billion operations per second. The iE33 systems interface brings innovative methods to echocardiography. For the first time, wireless voice recognition technology is available with our futuristic iCOMMAND. Its easy to learn and integrate into exams.
Info Philips Medical SystemsCall Philips Medical Systems to buy products (US and Canada only; other locations use number below) USACanada1-866-745-0519

Customer Service: 1-800-722-7900
Web site: http://www.medical.philips.com/

Related medicine products :

1. ACUSON Sequoia C512 Echocardiography System
2. A Practical Approach to Transesophageal Echocardiography
3. Silicone Oil Cannula System - 20 Gauge
4. Silicone Oil Cannula System - 19 Gauge
5. SuperVu Galilean System
6. KOWA nonmyd 7 / VK-2 Digital Imaging System
7. KOWA nonmyd a-D / VK-2 Digital Imaging System
8. Refraction System RT-2100
9. Odyssey Phacoemulsification System
10. SIStem Phacoemulsification System
11. Precisionist Phacoemulsification System
Microforceps: Claes ILM Forceps...
The Tano Asymmetrical Microforceps features an offset tip which allows optimal visualization along the entire tip length. Versatile tip design targets ILM, fine epiretinal membranes and diabetic or P...
Microforceps with "nail-like" end-gripping platforms; for precise grasping and improved visualization of thin membranes in the macular region....
Microforceps : Eckardt Endgripping Forceps...
Medicine Products:
(Date:7/6/2015)... ... July 06, 2015 , ... Dr. Lawrence Green is ... area patients. Kybella is a non-surgical method to dissolve fat cells and ... moderate to severe fat deposits under the chin, commonly known as a double chin. ...
(Date:7/6/2015)... ... July 06, 2015 , ... Promero, a leading cloud ... Software Unified IP contact center solution hosted by Promero. Randstad Technologies,a leading ... its future call center platform. , Promero will implement and manage the ...
(Date:7/6/2015)... Newport News, VA (PRWEB) , ... July 06, ... ... announced today that Dr. Jeffrey R. Carlson finished his 100th case using SpineFrontier’s® ... Bon Secours Mary Immaculate Hospital in Newport News, VA. The procedure was an ...
(Date:7/6/2015)... ... 06, 2015 , ... Diabetes affects many of us and the Glycemic Load ... diabetes, the majority of which are Type 2. However, eight million do not know ... three, have prediabetes (abnormally high blood sugar levels). Without reductions in blood sugar levels ...
(Date:7/6/2015)... Akron, OH (PRWEB) , ... July 06, 2015 , ... ... Home Health and Hospice received the Music & Memory Certification for hospice patients ... bringing the power of music not only to patients but also to their families ...
Breaking Medicine News(10 mins):Health News:Rockville, MD Practice Now Offering New FDA-Approved Non-Surgical Double Chin Treatment 2Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 2Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 3Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 3Health News:115 Million in the U.S. could beat diabetes with the help of a new app 2Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 2Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 3Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 4
... With sights set on advanced science degrees and careers ... now have the highest honor they can garner for ... Eastham, a junior chemistry major, and Thomas Markovich, a ... Barry M. Goldwater Scholars for the 2011-2012 academic year. ...
... 6, 2011 Researchers at The Scripps Research Institute have found ... to pour in and activate an immune response. This process can ... it fallssuch as when immune cells are "called" from the body,s ... The study, recently published online ahead of print by Nature ...
... international panel of experts from The Heart Rhythm Society ... recommendations for all health care professionals about cardiovascular genetic ... Sessions. Silvia G. Priori, MD, PhD, a ... director of the Cardiovascular Genetics Program at NYU Langone ...
... National Academies Keck Futures Initiative announced today the recipients ... to support interdisciplinary research on imaging science. The ... such research, which was the subject of the eighth ... "We received far more high-quality proposals than funds available," ...
... A study published in the June 2011 issue of ... the association between patientphysician gender concordance and weight-related counseling ... and Johns Hopkins University found that obese male patients ... counseling than obese women seeing a female physician. ...
... Reporter , THURSDAY, May 5 (HealthDay News) -- You stand ... while you,re in an exercise facility than if you,re in ... Overall, 50 percent of cardiac arrest victims survived ... sort of exercise was happening, whereas only 36 percent of ...
Cached Medicine News:Health News:2 students named Goldwater Scholars, 2 receive honorable mention 2Health News:2 students named Goldwater Scholars, 2 receive honorable mention 3Health News:Scripps Research scientists show how shifts in temperature prime immune response 2Health News:Scripps Research scientists show how shifts in temperature prime immune response 3Health News:New guidelines for cardiovascular genetic testing 2Health News:Keck Futures Initiative awards $1 million for 13 research projects 2Health News:Keck Futures Initiative awards $1 million for 13 research projects 3Health News:Keck Futures Initiative awards $1 million for 13 research projects 4Health News:Keck Futures Initiative awards $1 million for 13 research projects 5Health News:Weight-loss counseling most prevalent between male physicians and obese men 2Health News:Cardiac Arrest Less Deadly in Exercise Facilities, Study Finds 2Health News:Cardiac Arrest Less Deadly in Exercise Facilities, Study Finds 3
(Date:7/6/2015)... SUNNYVALE, Calif. , July 6, 2015   ... will report financial results for its 2015 second quarter ... after the close of the market. The ... Pacific Time on Thursday, July 23, 2015, to discuss ... Cepheid,s website at http://ir.cepheid.com at least 15 ...
(Date:7/6/2015)... and SOUTH SAN FRANCISCO, Calif. , ... AGN ), a leading global pharmaceutical company, and Oculeve, ... treatments for dry eye disease, today announced that they ... acquire Oculeve in an all-cash transaction.  Under the terms ... $125 million upfront payment and commercialization milestone payments related ...
(Date:7/6/2015)... July 6, 2015 Akcea Therapeutics, a ... ISIS ), announced today that the U.S. Food ... to volanesorsen (ISIS-APOCIII Rx ) for the treatment ... is a rare genetic disease characterized by extremely ... a Phase 2 study published in the NEJM ...
Breaking Medicine Technology:Allergan to Acquire Oculeve Dry Eye Disease Development Programs 2Allergan to Acquire Oculeve Dry Eye Disease Development Programs 3Allergan to Acquire Oculeve Dry Eye Disease Development Programs 4Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 2Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 3Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 4Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 5Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 6